NEW YORK – Which articles gained the most interest from GenomeWeb readers last week? Here are the top five:
- Guardant Health CRC Screening Results Spook Investors Despite Meeting Reimbursement Requirements
- Ravgen's NIPT Patents Found Valid in Administrative Challenge
- Agilent, Qiagen Nab FDA Approvals for Lung Cancer Treatment CDx
- Genomics England, NHS to Lead £105M UK Study with Aim to Sequence 100K Newborns
- Invitae Aims for Transparency With Newly Issued Patient Data Use Report